NCT05869682View on ClinicalTrials.gov

Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy

PHASE2RecruitingINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

July 9, 2024

Primary Completion Date

November 30, 2028

Study Completion Date

November 30, 2028

Conditions
Advanced Prostate CarcinomaMetastatic Prostate CarcinomaProstate CarcinomaStage III Prostate Cancer AJCC v8Stage IV Prostate Cancer AJCC v8
Interventions
PROCEDURE

Bright White Light Therapy

Wear AYOpro BWL therapy

DRUG

Combination Drug Therapy

Receive SOC ADT combination therapy

OTHER

Electronic Health Record Review

Ancillary studies

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

91010

RECRUITING

City of Hope Medical Center, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER